NCT05824325

Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer(GALAXY)

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: ACTIVE_NOT_RECRUITING

Phase: PHASE1, PHASE2

Sponsor: Fudan University

Condition: Breast Cancer

Signal summary

Public flags

Status signal: Low Signal

Timeline signals: stale_update_signal | primary_completion_date_past_signal | long_recruitment_duration_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

Context when available

No stop reason available in the current public record.